NCT05868226
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05868226
Title PRE-ISPY Phase I/II Oncology Platform Program (PRE-ISPY)
Acronym PRE-ISPY
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors QuantumLeap Healthcare Collaborative
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.